UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer

Science (American Association for the Advancement of Science), 2009-11, Vol.326 (5957), p.1230-1230

2009

Volltextzugriff (PDF)

Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo

Proceedings of the National Academy of Sciences - PNAS, 2016-05, Vol.113 (21), p.E2935-E2944

2016

Volltextzugriff (PDF)

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer

Nature communications, 2014-07, Vol.5 (1), Article 4527

2014

Volltextzugriff (PDF)

EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection

Pharmacology & therapeutics (Oxford), 2015-10, Vol.154, p.67-77

2015

Volltextzugriff (PDF)

TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling

Neoplasia (New York, N.Y.), 2020-04, Vol.22 (4), p.163-178

2020

Volltextzugriff (PDF)

Membrane Transition Temperature Determines Cisplatin Response

PloS one, 2015-10, Vol.10 (10), p.e0140925-e0140925

2015

Volltextzugriff (PDF)

KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation

Neoplasia (New York, N.Y.), 2014-02, Vol.16 (2), p.115-W5

2014

Volltextzugriff (PDF)

Wild-type EGFR Is Stabilized by Direct Interaction with HSP90 in Cancer Cells and Tumors

Neoplasia (New York, N.Y.), 2012-08, Vol.14 (8), p.670-IN1

2012

Volltextzugriff (PDF)

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

Translational oncology, 2019-02, Vol.12 (2), p.209-216

2019

Volltextzugriff (PDF)

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy

Neoplasia (New York, N.Y.), 2015-09, Vol.17 (9), p.697-703

2015

Volltextzugriff (PDF)

Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (7), p.2862-2869

2010

Volltextzugriff (PDF)

Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer

Clinical cancer research, 2011-09, Vol.17 (17), p.5755-5764

2011

Volltextzugriff (PDF)

Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization

Aging (Albany, NY.), 2023-07, Vol.15 (13), p.6011-6030

2023

Volltextzugriff (PDF)

Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts

Neoplasia (New York, N.Y.), 2014-02, Vol.16 (2), p.105-W2

2014

Volltextzugriff (PDF)

Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2

Neoplasia (New York, N.Y.), 2011-07, Vol.13 (7), p.570-IN1

2011

Volltextzugriff (PDF)

The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model

Cell reports (Cambridge), 2022-12, Vol.41 (12), p.111837, Article 111837

2022

Volltextzugriff (PDF)

Investigating NanoLuc-EGFR engineered cell lines for real-time monitoring of EGFR protein dynamics in live cells

Biochemical and biophysical research communications, 2024-11, Vol.733, p.150711, Article 150711

2024

Volltextzugriff (PDF)

Tristetraprolin mediates radiation-induced TNF-α production in lung macrophages

PloS one, 2013-02, Vol.8 (2), p.e57290-e57290

2013

Volltextzugriff (PDF)

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Nature (London), 2009-02, Vol.457 (7231), p.910-914

2009

Volltextzugriff (PDF)

Integration of EGFR inhibitors with radiochemotherapy

Nature reviews. Cancer, 2006-11, Vol.6 (11), p.876-885

2006

Volltextzugriff (PDF)

Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance

The Journal of biological chemistry, 2020-09, Vol.295 (36), p.12661-12673

2020

Volltextzugriff (PDF)

Radiosensitization by Pan ErbB Inhibitor CI-1033 in Vitro and in Vivo

Clinical cancer research, 2004-01, Vol.10 (2), p.691-700

2004

Volltextzugriff (PDF)

Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts

Clinical cancer research, 2020-10, Vol.26 (19), p.5246-5257

2020

Volltextzugriff (PDF)

Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab

Molecular therapy, 2022-01, Vol.30 (1), p.468-484

2022

Volltextzugriff (PDF)

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo

Clinical cancer research, 2007-04, Vol.13 (8), p.2512-2518

2007

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(83)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(44)
Humans
(42)
Oncology
(32)
Animals
(31)
Cell Line, Tumor
(21)
Mice
(21)
Biological And Medical Sciences
(13)
Mice, Nude
(13)
Medical Sciences
(12)
Tumors
(11)
Egfr
(9)
Female
(9)
Antineoplastic Agents
(8)
Antineoplastic Agents - Pharmacology
(8)
Cho Cells
(8)
Erbb Receptors - Metabolism
(8)
Male
(8)
Pharmacology. Drug Treatments
(8)
Phosphorylation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer

Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer

EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection

TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling

Membrane Transition Temperature Determines Cisplatin Response

KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation

Wild-type EGFR Is Stabilized by Direct Interaction with HSP90 in Cancer Cells and Tumors

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy

Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer

Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer

Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization

Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts

Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2

The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model

Investigating NanoLuc-EGFR engineered cell lines for real-time monitoring of EGFR protein dynamics in live cells

Tristetraprolin mediates radiation-induced TNF-α production in lung macrophages

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Integration of EGFR inhibitors with radiochemotherapy

Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance

Radiosensitization by Pan ErbB Inhibitor CI-1033 in Vitro and in Vivo

Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts

Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo

Suchergebnisse filtern